Sigma Advanced Systems SIGMAADV

Summary

Strip away the corporate history and there is a real business here: Sigma Advanced Systems Pvt Ltd, a Hyderabad avionics and defence-electronics firm with roots reported anywhere from 1994 to 1999, plus two genuine UK acquisitions — Nasmyth Group (£17.8m, ~500 employees, ~£60m revenue, supplies Rolls-Royce, Boeing, Airbus, GE Aerospace, Safran) and Bromford Precision Solutions (£11.89m, aero-engine rings/casings, Rolls-Royce and Siemens approved) — that give it real, Nadcap-adjacent aerospace manufacturing capability in two countries, and two Rolls-Royce long-term agreements (£300m and a further £125m) that are not in dispute.

What is unusual, and what this report cannot look past, is how the public company came to exist. This is not an IPO. Sigma became listed through an NCLT-sanctioned reverse merger into Megasoft Limited, a 27-year-old, near-zero-revenue dormant telecom-billing shell, completed 31 December 2025 and rebranded in early 2026 (sources disagree on the exact rebrand date: 12 January vs 9 February). The controlling promoter group, Chintalapati Holdings, acquired its 46.31% stake entirely through the share-swap mechanics of that merger — not through open-market conviction buying — and total promoter holding jumped from 35% to 71% in a single quarter as a direct result.

The FY26 numbers that the ~₹832 share price is being valued against are dominated by one-off gains: a ₹184.64cr land-sale gain and a ~₹137.6cr gain on divesting a stake in Extrovis AG, not by underlying operating profit. The BSE itself issued a formal query on unusual volume and price movement in May 2026. Independent analysis found in this research states its conclusion plainly: "watch, not buy, until at least two to three quarters of FY27 results" provide a clean read.

Net: SELL. The underlying manufacturing assets may well be good; the stock, at ~48-95x P/E on earnings that are substantially one-off, priced by a market that has not yet seen a single clean full year of consolidated results, is not.

• Genuine aero-engine manufacturing capability, not a paper asset. Nasmyth Group is a ~75-year- old UK precision aerospace manufacturer with ~500 employees and disclosed Rolls-Royce, Boeing, Airbus, GE Aerospace and Safran customer relationships predating the acquisition.
• Two confirmed, sizeable Rolls-Royce long-term agreements. A £300m 7-year LTA (April 2026) and a further £125m (~$170m) agreement for engine rings/casings (August 2026), dual-sourced from India and UK — a combined ~£425m of disclosed contracted value.
• A genuinely broad defence-electronics product base. Missile sub-systems, naval electronics, avionics, radar/EW, counter-UAS and precision munitions give the underlying business more diversification than a single-platform supplier.
• Real revenue growth even excluding one-offs. Standalone Q3 FY26 (pre-Nasmyth consolidation) revenue grew 50.6% YoY — a genuine, if smaller-scale, operating improvement independent of the headline one-off-driven profit figure.

• This is a reverse merger into a dormant shell, not an IPO. The public company's entire listed history is nine months old at the time of this report, and its 71%+ promoter stake was acquired via a fixed share-swap ratio, not open-market purchase at a market-tested price.
• FY26 "profit" is substantially one-off. A ₹184.64cr land-sale gain and a ~₹137.6cr Extrovis AG stake-divestment gain, not operating earnings, explain most of the swing from a FY25 loss to a large FY26 profit. Third-party analysis (Tijori Finance) explicitly flagged this.
• The exchange itself flagged the stock. BSE issued a formal query on unusual volume and price movement in May 2026 — a direct, exchange-level governance signal, not a third-party opinion.
• The promoter's controlling individual carries a disclosed, if ultimately overturned, regulatory history. Chintalapati Srinivasa Raju was found by SEBI to have committed insider trading in the Satyam-era scandal (2009); the Supreme Court of India overturned that finding in 2018. Given his current 46.31% direct stake, this is a material disclosure point regardless of the final legal outcome.
• The deal pace itself is a flagged risk. Three acquisitions across two continents inside 14 months is the kind of integration load that, per independent analysis cited in this research, has historically caused significant operational disruption at a meaningful base rate for comparable cross-border precision-engineering deals.
• At least one program attribution is disputed. A claimed Barak-8 (LRSAM/MRSAM) contract has been publicly questioned by at least one independent commentator, who suggests the work may actually belong to a different company (Cyient DLM) and questions whether Sigma holds the specific Nadcap Circuit Card Assembly certification the work would require. This report could not resolve the dispute either way.
• Basic governance facts remain unverified. Full board roster, independent-director percentage and statutory auditor identity could not be confirmed in this research.

• FY27 quarterly results — the specific bar independent analysis has set before this valuation can be trusted.
• Resolution of the Barak-8 program attribution dispute.
• Any follow-up to the BSE's May 2026 volume/price query.
• Funding source and timeline for the announced but reportedly unfunded ~₹450cr expansion capex.

• Earnings-quality risk (dominant). Current profitability is not representative of sustainable operating earnings.
• Listing-structure risk. A reverse merger carries different disclosure and track-record dynamics than a conventional IPO, and this one is genuinely untested.
• Integration risk across three acquisitions in 14 months.
• Concentration-of-control risk given the promoter's 66-71% stake acquired via share swap.

We deliberately do not value this stock off FY26 reported PAT (₹268cr), since roughly ₹322cr of that period's other income is one-off (land sale + Extrovis AG divestment) and would, if excluded, imply a core operating loss or near-breakeven result for the period. Instead we anchor to the cleaner, pre- Nasmyth standalone run-rate: Q3 FY26 standalone net profit of ₹13.01cr, annualised (~4x) to ~₹52cr, using Screener's implied share count (market cap ÷ price ≈ 19.0cr shares):

Even our bull case, generously assuming the UK acquisitions add ₹100-150cr of clean, annualised PAT on top of the standalone base (an indicative construction, not a disclosed consolidated forecast), does not approach the current ₹832 share price. We set our target at ₹450 — above even this generous bull case — solely to reflect that the underlying assets (Nasmyth, Bromford, the Rolls-Royce LTAs) have real, disclosed value that a pure "clean earnings" multiple may understate during an integration period, while still requiring a substantial correction from current levels.

Source: Screener.in; substack analyses (manthanrastogi, asymmetricequities) cross- referencing NCLT filings and company disclosures; Business Standard/airforce-technology.com (Rolls-Royce contracts); all dated September 2026 research.